Literature DB >> 27929737

Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.

Tao Li1, Xiao-Dong Yang1, Chun-Xiang Ye1, Zhan-Long Shen1, Yang Yang1, Bo Wang1, Peng Guo1, Zhi-Dong Gao1, Ying-Jiang Ye1, Ke-Wei Jiang1, Shan Wang1.   

Abstract

Accumulating evidence suggests that long noncoding RNAs (lncRNAs) play an important role in oncogenesis and tumor progression. However, our knowledge of lncRNAs in thyroid cancer is still limited. To explore the crucial lncRNAs involved in oncogenesis of papillary thyroid cancer (PTC), we acquired data of differentially expressed lncRNAs between PTC tissues and paired adjacent noncancerous thyroid tissues through lncRNA microarray. In the microarray data, we observed that a newly identified lncRNA, HIT000218960, was significantly upregulated in PTC tissues and associated with a well-known oncogene, high mobility group AT-hook 2 (HMGA2) gene. Both in normal thyroid tissues and PTC tissues, the expression of HIT000218960 was significantly positively correlated with that of HMGA2 mRNA. Knockdown of HIT000218960 in PTC cells resulted in downregulation of HMGA2. In addition, functional assays indicated that inhibition of HIT000218960 in PTC cells suppressed cell proliferation, colony formation, migration and invasion in vitro. Increased HIT000218960 expression in PTC tissues was obviously correlated with lymph node metastasis and multifocality, as well as TNM stage. Those findings suggest that HIT000218960 might acts as a tumor promoter through regulating the expression of HMGA2.

Entities:  

Keywords:  HIT000218960; HMGA2; long noncoding RNA; oncogenesis; papillary thyroid cancer

Mesh:

Substances:

Year:  2016        PMID: 27929737      PMCID: PMC5283824          DOI: 10.1080/15384101.2016.1261768

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Authors:  Jaroslaw Jendrzejewski; Andrew Thomas; Sandya Liyanarachchi; Andrew Eiterman; Jerneja Tomsic; Huiling He; Hanna S Radomska; Wei Li; Rebecca Nagy; Krzysztof Sworczak; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2015-08-14       Impact factor: 5.958

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.

Authors:  Mateus Camargo Barros-Filho; Fabio Albuquerque Marchi; Clóvis Antônio Pinto; Silvia Regina Rogatto; Luiz Paulo Kowalski
Journal:  J Clin Endocrinol Metab       Date:  2015-04-13       Impact factor: 5.958

Review 4.  The HMGA proteins: a myriad of functions (Review).

Authors:  Isabelle Cleynen; Wim J M Van de Ven
Journal:  Int J Oncol       Date:  2008-02       Impact factor: 5.650

5.  Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans.

Authors:  Denis Dupuy; Nicolas Bertin; César A Hidalgo; Kavitha Venkatesan; Domena Tu; David Lee; Jennifer Rosenberg; Nenad Svrzikapa; Aurélie Blanc; Alain Carnec; Anne-Ruxandra Carvunis; Rock Pulak; Jane Shingles; John Reece-Hoyes; Rebecca Hunt-Newbury; Ryan Viveiros; William A Mohler; Murat Tasan; Frederick P Roth; Christian Le Peuch; Ian A Hope; Robert Johnsen; Donald G Moerman; Albert-László Barabási; David Baillie; Marc Vidal
Journal:  Nat Biotechnol       Date:  2007-05-07       Impact factor: 54.908

6.  HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.

Authors:  Gennaro Chiappetta; Angelo Ferraro; Emilia Vuttariello; Mario Monaco; Francesca Galdiero; Veronica De Simone; Daniela Califano; Pierlorenzo Pallante; Gerardo Botti; Luciano Pezzullo; Giovanna Maria Pierantoni; Massimo Santoro; Alfredo Fusco
Journal:  Eur J Cancer       Date:  2008-03-28       Impact factor: 9.162

7.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

8.  Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.

Authors:  Liang Deng; Shi-Bin Yang; Feng-Feng Xu; Ji-Hong Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-02-19

9.  HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma.

Authors:  You-You Xia; Li Yin; Hao Tian; Wen-Jie Guo; Ning Jiang; Xue-Song Jiang; Jing Wu; Meng Chen; Jian-Zhong Wu; Xia He
Journal:  Onco Targets Ther       Date:  2015-01-17       Impact factor: 4.147

Review 10.  High mobility group a proteins as tumor markers.

Authors:  Pierlorenzo Pallante; Romina Sepe; Francesca Puca; Alfredo Fusco
Journal:  Front Med (Lausanne)       Date:  2015-03-25
View more
  22 in total

Review 1.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

2.  Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway.

Authors:  Xiaoyu Li; Qinghuai Li; Xiao Jin; Hao Guo; Yong Li
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

3.  Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis.

Authors:  Sina Dadafarin; Michelle Carnazza; Humayun K Islam; Augustine Moscatello; Raj K Tiwari; Jan Geliebter
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  lncRNA HIT000218960 enhances resistance to 5-fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells.

Authors:  Li Bai; Kunbo Dong; Deyong Tong; Xiuna Shi; Sirong Wei; Yongguo Cai
Journal:  Exp Ther Med       Date:  2022-06-17       Impact factor: 2.751

5.  Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.

Authors:  Cunrong Chen; Lili Zhou; Hui Wang; Junnian Chen; Wen Li; Wei Liu; Mingjie Shen; Hongzhou Liu; Xiaomin Fu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

Review 6.  Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.

Authors:  Xiaobo Luo; Yan Qiu; Yuchen Jiang; Fangman Chen; Lu Jiang; Yu Zhou; Hongxia Dan; Xin Zeng; Yu L Lei; Qianming Chen
Journal:  Mol Cancer       Date:  2018-01-24       Impact factor: 27.401

7.  High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.

Authors:  Dan Nie; Lingping Zhang; Qian Guo; Xiguang Mao
Journal:  Oncotarget       Date:  2017-12-10

8.  LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.

Authors:  Xin Pan; Da Li; Jianing Huo; Fanfei Kong; Hui Yang; Xiaoxin Ma
Journal:  Cell Death Dis       Date:  2018-02-21       Impact factor: 8.469

9.  Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion.

Authors:  Yanzhuo Luo; Bingjin Li; Guangxin Zhang; Yuxiao He; Jeeyoo Hope Bae; Fengping Hu; Ranji Cui; Runhua Liu; Zhou Wang; Lizhong Wang
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

10.  Long noncoding RNA LINC01510 promotes the growth of colorectal cancer cells by modulating MET expression.

Authors:  Chaoqun Cen; Jian Li; Jingjing Liu; Mingshi Yang; Tianyi Zhang; Yu Zuo; Changwei Lin; Xiaorong Li
Journal:  Cancer Cell Int       Date:  2018-03-21       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.